Dr. Quiery is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
21 Hospital Dr
4th Floor
Asheville, NC 28801Phone+1 828-253-4262
Education & Training
- Creighton University, School of MedicineMaster of Science, Health Care Ethics, 2011 - 2014
- Stony Brook MedicineFellowship, Blood Banking/Transfusion Medicine, 1990 - 1992
- Duke University HospitalFellowship, Hematology and Medical Oncology, 1988 - 1989
- Stony Brook Medicine/University HospitalResidency, Internal Medicine, 1984 - 1988
- Albert Einstein College of MedicineClass of 1984
- Stony Brook UniversityB.S, Biochemistry, Phi Beta Kappa, 1976 - 1980
Certifications & Licensure
- TN State Medical License 2023 - 2026
- NC State Medical License 2019 - 2025
- MI State Medical License 2014 - 2021
- PA State Medical License 1991 - 2014
- NY State Medical License 1985 - 1992
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Pathology Blood Banking/Transfusion Medicine
Awards, Honors, & Recognition
- Alpha Omega Alpha Stony Brook University School of Medicine, 1987
- Phi Beta Kappa SUNY Stony Brook, 1980
- Fellow (FACP) American College of Physicians, 2005
Publications & Presentations
PubMed
- 69 citationsSafety and efficacy of avapritinib in advanced systemic mastocytosis: the phase 1 EXPLORER trial.Daniel J DeAngelo, Deepti H Radia, Tracy I George, William A Robinson, Albert T Quiery
Nature Medicine. 2021-12-01 - 185 citationsRuxolitinib in adult patients with secondary haemophagocytic lymphohistiocytosis: an open-label, single-centre, pilot trial.Asra Ahmed, Samuel A. Merrill, Fares Alsawah, Paula L. Bockenstedt, Erica L. Campagnaro
The Lancet. Haematology. 2019-09-16 - 69 citationsNCCN guidelines® insights: Chronic myeloid leukemia, version 1.2017: Featured updates to the NCCN guidelinesArnel Pallera, Jessica K. Altman, Ellin Berman, Camille N. Abboud, Bhavana Bhatnagar
Journal of the National Comprehensive Cancer Network. 2016-12-01
Professional Memberships
- Fellow
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: